|
1
|
Chowdhury AR, Ghosh I and Datta K:
Excessive reactive oxygen species induces apoptosis in fibroblasts:
Role of mitochondrially accumulated hyaluronic acid binding protein
1 (HABP1/p32/gC1qR). Exp Cell Res. 314:651–667. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Majumdar M, Meenakshi J, Goswami SK and
Datta K: Hyaluronan binding protein 1 (HABP1)/C1QBP/p32 is an
endogenous substrate for MAP kinase and is translocated to the
nucleus upon mitogenic stimulation. Biochem Biophys Res Commun.
291:829–837. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ghebrehiwet B and Peerschke EI: cC1q-R
(calreticulin) and gC1q-R/p33: Ubiquitously expressed multi-ligand
binding cellular proteins involved in inflammation and infection.
Mol Immunol. 41:173–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tahtouh M, Garçon-Bocquet A, Croq F,
Vizioli J, Sautière PE, van Camp C, Salzet M, Nagnan-le Meillour P,
Pestel J and Lefebvre C: Interaction of HmC1q with leech microglial
cells: Involvement of C1qBP-related molecule in the induction of
cell chemotaxis. J Neuroinflammation. 9:372012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
McGee AM, Douglas DL, Liang Y, Hyder SM
and Baines CP: The mitochondrial protein C1qbp promotes cell
proliferation, migration and resistance to cell death. Cell Cycle.
10:4119–4127. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dembitzer FR, Kinoshita Y, Burstein D,
Phelps RG, Beasley MB, Garcia R, Harpaz N, Jaffer S, Thung SN,
Unger PD, et al: gC1qR expression in normal and pathologic human
tissues: Differential expression in tissues of epithelial and
mesenchymal origin. J Histochem Cytochem. 60:467–474. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang X, Zhang F, Guo L, Wang Y, Zhang P,
Wang R, Zhang N and Chen R: Interactome analysis reveals that C1QBP
(complement component 1, q subcomponent binding protein) is
associated with cancer cell chemotaxis and metastasis. Mol Cell
Proteomics. 12:3199–3209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rubinstein DB, Stortchevoi A, Boosalis M,
Ashfaq R, Ghebrehiwet B, Peerschke EI, Calvo F and Guillaume T:
Receptor for the globular heads of C1q (gC1q-R, p33,
hyaluronan-binding protein) is preferentially expressed by
adenocarcinoma cells. Int J Cancer. 110:741–750. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen YB, Jiang CT, Zhang GQ, Wang JS and
Pang D: Increased expression of hyaluronic acid binding protein 1
is correlated with poor prognosis in patients with breast cancer. J
Surg Oncol. 100:382–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu H, Liu Q, Xin T, Xing L, Dong G, Jiang
Q, Lv Y, Song X, Teng C, Huang D, et al: Elevated expression of
hyaluronic acid binding protein 1 (HABP1)/P32/C1QBP is a novel
indicator for lymph node and peritoneal metastasis of epithelial
ovarian cancer patients. Tumour Biol. 34:3981–3987. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Amamoto R, Yagi M, Song Y, Oda Y,
Tsuneyoshi M, Naito S, Yokomizo A, Kuroiwa K, Tokunaga S, Kato S,
et al: Mitochondrial p32/C1QBP is highly expressed in prostate
cancer and is associated with shorter prostate-specific antigen
relapse time after radical prostatectomy. Cancer Sci. 102:639–647.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Itahana K and Zhang Y: Mitochondrial p32
is a critical mediator of ARF-induced apoptosis. Cancer Cell.
13:542–553. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sunayama J, Ando Y, Itoh N, Tomiyama A,
Sakurada K, Sugiyama A, Kang D, Tashiro F, Gotoh Y, Kuchino Y and
Kitanaka C: Physical and functional interaction between BH3-only
protein Hrk and mitochondrial pore-forming protein p32. Cell Death
Differ. 11:771–781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meenakshi J, Goswami SK Anupama and Datta
K: Constitutive expression of hyaluronan binding protein 1
(HABP1/p32/gC1qR) in normal fibroblast cells perturbs its growth
characteristics and induces apoptosis. Biochem Biophys Res Commun.
300:686–693. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kamal A and Datta K: Upregulation of
hyaluronan binding protein 1 (HABP1/p32/gC1qR) is associated with
Cisplatin induced apoptosis. Apoptosis. 11:861–874. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hosseinimehr SJ, Nobakht R, Ghasemi A and
Pourfallah TA: Radioprotective effect of mefenamic acid against
radiation-induced genotoxicity in human lymphocytes. Radiat Oncol
J. 33:256–260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han S, Bui NT, Ho MT, Kim YM, Cho M and
Shin DB: Dexamethasone inhibits TGF-β1-induced cell migration by
regulating the ERK and AKT pathways in human colon cancer cells via
CYR61. Cancer Res Treat. 48:1141–1153. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim ST, Park KH, Kim JS, Shin SW and Kim
YH: Impact of KRAS mutation status on outcomes in metastatic colon
cancer patients without anti-epidermal growth factor receptor
therapy. Cancer Res Treat. 45:55–62. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee JH, Kim KH, Park JW, Chang HJ, Kim BC,
Kim SY, Kim KG, Lee ES, Kim DY, Oh JH, et al: Low-mass-ion
discriminant equation: A new concept for colorectal cancer
screening. Int J Cancer. 134:1844–1853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim KH, Yeo SG, Kim WK, Kim DY, Yeo HY,
Hong JP, Chang HJ, Park JW, Kim SY, Kim BC and Yoo BC: Up-regulated
expression of l-caldesmon associated with malignancy of colorectal
cancer. BMC Cancer. 12:6012012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su F, Grijalva V, Navab K, Ganapathy E,
Meriwether D, Imaizumi S, Navab M, Fogelman AM, Reddy ST and
Farias-Eisner R: HDL mimetics inhibit tumor development in both
induced and spontaneous mouse models of colon cancer. Mol Cancer
Ther. 11:1311–1319. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cho O, Hwang HS, Lee BS, Oh YT, Kim CH and
Chun M: Met inactivation by S-allylcysteine suppresses the
migration and invasion of nasopharyngeal cancer cells induced by
hepatocyte growth factor. Radiat Oncol J. 33:328–336. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van Duijnhoven FJ, Bueno-De-Mesquita HB,
Calligaro M, Jenab M, Pischon T, Jansen EH, Frohlich J, Ayyobi A,
Overvad K, Toft-Petersen AP, et al: Blood lipid and lipoprotein
concentrations and colorectal cancer risk in the European
prospective investigation into cancer and nutrition. Gut.
60:1094–1102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Halley P, Kadakkuzha BM, Faghihi MA,
Magistri M, Zeier Z, Khorkova O, Coito C, Hsiao J, Lawrence M and
Wahlestedt C: Regulation of the apolipoprotein gene cluster by a
long noncoding RNA. Cell Rep. 6:222–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Zhao XW, Liu DB, Han CZ, Du LL,
Jing JX and Wang Y: Lipid levels in serum and cancerous tissues of
colorectal cancer patients. World J Gastroenterol. 20:8646–8652.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Su F, Kozak KR, Imaizumi S, Gao F, Amneus
MW, Grijalva V, Ng C, Wagner A, Hough G, Farias-Eisner G, et al:
Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit
tumor development in a mouse model of ovarian cancer. Proc Natl
Acad Sci USA. 107:19997–20002. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Dai S, Zhang Z, Liu L, Wang J,
Xiao X, He D and Liu B: Characterization of apolipoprotein A-I as a
potential biomarker for cholangiocarcinoma. Eur J Cancer Care
(Engl). 18:625–635. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang R, Yang ZH, Luo DH, Guo L, Sun R,
Chen QY, Huang PY, Qiu F, Zou X, Cao KJ, et al: Elevated
apolipoprotein A-I levels are associated with favorable prognosis
in metastatic nasopharyngeal carcinoma. Med Oncol. 31:802014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tachibana M, Ohkura Y, Kobayashi Y,
Sakamoto H, Tanaka Y, Watanabe J, Amikura K, Nishimura Y and Akagi
K: Expression of apolipoprotein A1 in colonic adenocarcinoma.
Anticancer Res. 23:4161–4167. 2003.PubMed/NCBI
|
